EP0496841B1 - Ausrüstung zum inaktivieren der keimschicht bei der fluidisierungstherapie - Google Patents

Ausrüstung zum inaktivieren der keimschicht bei der fluidisierungstherapie Download PDF

Info

Publication number
EP0496841B1
EP0496841B1 EP91909550A EP91909550A EP0496841B1 EP 0496841 B1 EP0496841 B1 EP 0496841B1 EP 91909550 A EP91909550 A EP 91909550A EP 91909550 A EP91909550 A EP 91909550A EP 0496841 B1 EP0496841 B1 EP 0496841B1
Authority
EP
European Patent Office
Prior art keywords
chamber
air
support basin
pressure
evaporator
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
EP91909550A
Other languages
English (en)
French (fr)
Other versions
EP0496841A1 (de
Inventor
Victor George Ryhiner
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
REDITAC BV
Original Assignee
REDITAC BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=19857152&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=EP0496841(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by REDITAC BV filed Critical REDITAC BV
Publication of EP0496841A1 publication Critical patent/EP0496841A1/de
Application granted granted Critical
Publication of EP0496841B1 publication Critical patent/EP0496841B1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61G—TRANSPORT, PERSONAL CONVEYANCES OR ACCOMMODATION SPECIALLY ADAPTED FOR PATIENTS OR DISABLED PERSONS; OPERATING TABLES OR CHAIRS; CHAIRS FOR DENTISTRY; FUNERAL DEVICES
    • A61G7/00—Beds specially adapted for nursing; Devices for lifting patients or disabled persons
    • A61G7/05—Parts, details or accessories of beds
    • A61G7/057—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor
    • A61G7/05738—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads
    • A61G7/05746—Arrangements for preventing bed-sores or for supporting patients with burns, e.g. mattresses specially adapted therefor with fluid-like particles, e.g. sand, mud, seeds, gel, beads fluidised by air flow

Definitions

  • the invention relates to a system for extracting moisture and fluid from one or more bodies, comprising a support basin accommodating moisture absorbing beads, a pressure chamber in air communication with the support basin, an air supply system for supplying air to the pressure chamber, and an evaporator chamber interconnected in the air supply path for extracting moisture from the supplied air.
  • the system known from EP-A-0332242 comprises a support basin, in which beads are accommodated.
  • a pressure is built up in a pressure chamber in communication with said support basin.
  • the pressure chamber is connected to an air supply system.
  • the moisture in the supplied air is removed by an evaporated chamber, in which an evaporator is arranged for lowering the temperature of the supplied air such that vapour droplets results.
  • the vapour droplets are collected in a cabinet part provided with a heating member for evaporating the vapour droplets. Then the evaporated droplets are removed into the ambient air.
  • This invention has the object to provide a system as mentioned above, by which the therapy is completely excessible to all parts of the world, thus also those with a high humidity degree and temperature. Consequently, it is necessary to reach a development, by which a continuous dehydration system will be present, so that under all climato-logical circumstances, a relative humidity degree of the floatation medium of less than 40% is reached.
  • the system is not being applied to therapeutical purposes only, but can also be used for industrial and/or agrarian products.
  • the principal aim, however, is to treat patients with severe tissue deformation in the gradation from excematic to gangrenous deformation, therapeutically and sterile, without the risk of contamination or cossinfection.
  • the above-mentioned aim is achieved in that the evaporator chamber is in communication with a depression chamber through a reference leak.
  • the optimum therapeutical depth by means of this system is reached at indication of burns 1-3 degrees, skin grafts and autografts, intensive and coronary care units, atrophy, geriatrics and many other applications, by which very vulnerable tissue is involved.
  • the system is based on the principle, by which the entering air, as well as the vapour tension coming from the absorbing microspheres, will extracted from moisture continuously. Owing to this, an air entrance will occur, which is ⁇ RH 40% at a temperature adjustable from 26°C (lower than the body temperature) to 38°C (higher than the body temperature), independent from the ambient temperature.
  • the viscosity is, also because of the low sg of the microspheres, 1.2 and brought in a fluidized state that could be compared with dry water with a RH ⁇ 40%.
  • the body in its shape will be covered almost completely by the microspheres, which will benefit the therapy, also because of the subcapillary pressure of ⁇ 8mm/HG and the bubbling effect of the fluidized mass.
  • the dissipated heat from the condensing unit will be utilized at the demand for heating of the flotation medium, so that a recirculation of the dissipated heat will hardly influence the ambient temperature.
  • all moisture which will be extracted from the surroundings as well as the contents of the equipment will be recirculated into the ambient, in this manner making the atmosphere where the patient is being treated, pleasant, as a result of a higher humidity. Also the ambient temperature will hardly increase.
  • the equipment of the invention could be devided into three main components:
  • the operation of the invention is based on the following principle: (see figure 1).
  • the ambient air will, after passing the dustfilter F1, pass the evaporator F2. Since the evaporator is brought to a temperature of 5°C, water-particles will be precipitated on the evaporator and will condensate.
  • the evaporator chamber F2 is connected with the vacuum chamber F3 by means of a reference leak.
  • the vacuum chamber F3 is connected to a vacuum pump or other venturi mechanism, in order to reach the desired underpressure. Causing an average vacuum pressure of 0,1mm/H2O, the boilingpoint of the water will be lowered and atomized again into the ambient.
  • the air from which the water-particles have been extracted will be carried to a twostage air compressor F4, where it will reach a pressure of 500mm/H2O under the fluidization compartment as installed in F5.
  • the hygrostat which has been installed will deactivate the condensing unit and evaporator, after the flotation material (microspheres) has reached the relative humidity degree of 35% (constant dehydration mode).
  • the fluidization pressure of 500mm/H2O is enough to "boil" the mass ( ⁇ 550 kg microspheres) in the basin F5, with a viscosity of 1.0-1.2.
  • basin F5 is adjustable in height from 65-85cm or from 80-100cm, measured from the floor surface, by means of an electric- or otherwise applied lifting system.
  • the therapeutical basin is equipped with a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C).
  • a molecular polyethylene fluidization sheet with a surface permeability of 5-20 ⁇ and a pressure drop of 20.5mBar (see figure 2 drawing C).
  • an equal and smooth fluidization is only possible at an absolute horizontal installation of the unit (see figure 2 drawing B).
  • the fluidization will be equally shifted in a varied liquid and solid mass of the microspheres. With this not only an enclosure of the tissue as well as the body is reached, but a petrissage therapy will take effect, which will stimulate the circulation of the blood and reduce the pains, also as a result of the dehydration system.
  • the modulating rotation system of the basin is connected to the existing lifting system and can be adjusted in time values from 10-60 minutes by means of an electronic control.
  • the basin is held in a horizontal position of 90° (see figure 2 drawing B).
  • the carrying profile has been provided with a mechanical level adjustment (see figure 3 part A). With this is achieved that the fluidization pressure measured on each part of the body, will remain constant.
  • the pulse therapy is built in as standard equipment, in order to eliminate sliding forces and traction formation as much as possible.
  • the flotation material By reducing the fluidization pressure to the critical value of 250mm/H2O, the flotation material (microspheres) will remain air permeable and "mould" the body of the patient in a firm shape. By reducing the volume of the air compressor to 80M3 per hour, a reduction of the working pressure will be achieved. The temperature control as well as drain of moisture from the body will remain active. The electronic adjustment of the pulse therapy can be controlled in period intervals of 1-10 minutes passive and 1-10 seconds active.

Landscapes

  • Health & Medical Sciences (AREA)
  • Nursing (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Accommodation For Nursing Or Treatment Tables (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Devices For Medical Bathing And Washing (AREA)

Claims (12)

  1. System zum Entziehen von Feuchtigkeit und Fluid von einem oder mehreren Körpern, umfassend ein feuchtigkeitsabsorbierende Perlen aufnehmendes Haltebecken (F5), eine Druckkammer in Luftverbindung mit dem Haltebecken, ein Luftzufuhrsystem (F1, F4) zur Zufuhr von Luft zu der Druckkammer und eine in den Luftzufuhrweg zwischengeschaltete Verdampfungskammer (F2) zum Entziehen von Feuchtigkeit aus der zugeführten Luft, dadurch gekennzeichnet, daß die Verdampfungskammer (F2) mit einer Unterdruckkammer (F3) durch ein Referenzleck in Verbindung steht.
  2. System nach Anspruch 1, dadurch gekennzeichnet, daß die Unterdruckkammer mit einer Vakuumpumpe verbunden ist.
  3. System nach Anspruch 1, dadurch gekennzeichnet, daß die Unterdruckkammer mit einem Venturimechanismus verbunden ist.
  4. System nach Anspruch 1, 2 oder 3, bei dem der Verdampfer in der Verdampfungskammer (F2) durch eine Kondensiereinheit bestehend aus einem Kompressor (F8) und einem Kondensator (F9) gesteuert wird und bei dem der Kompressor durch einen in der Druckkammer angeordneten Hygrostat gesteuert wird.
  5. System nach Anspruch 4, bei dem der Kondensator in einem Gehäuse aufgenommen ist, das mit dem Zufuhrsystem mittels Leitungen und eines darin zwischengeschalteten Luftventils (F7) verbunden ist.
  6. System nach einem der vorangehenden Ansprüche, bei dem die Perlen hohle Mikrokugeln sind, mit einem Durchmesser bevorzugt größer als 100 µ und einer zur Massendichte vergleichbaren spezifischen Einheitsdichte g/cm3 kleiner als 2,2 passiv (nicht fluidisierend).
  7. System nach einem der Ansprüche 1 - 5, bei dem die Perlen nicht fest sind, um eine niedrigere relative Einheitsdichte pro Masse zu erreichen, und zwar vergleichbar zum Massendichtewert zunehmend 1 - 1,2 g/cm3 aktiv (fluidisierend).
  8. System nach einem der vorangehenden Ansprüche, bei dem das Haltebecken, das durch eine durchlässige Bahn für den Körper, von dem Feuchtigkeit entzogen werden sollte, bedeckt ist, mit einem elektrischen oder einem anderen Hebesystem versehen ist, um das Liegeniveau zur Bodenoberfläche von 65 - 85 cm oder von 80 - 100 cm zu variieren.
  9. System nach einem der vorangehenden Ansprüche, bei dem die Anwendung nicht nur auf medizinische/therapeutische Behandlungen beschränkt ist, sondern auch auf Bettsysteme für Heimverwendung angewendet wird.
  10. System nach einem der vorangehenden Ansprüche, bei dem das Haltebecken mit einem Winkel von 4° bezüglich des Horizontalniveaus moduliert werden kann, um einen intermittierenden Einschluß des Körpers und des Gewebes zu erreichen.
  11. System nach einem der vorangehenden Ansprüche, bei dem der Fluidisierungsdruck im Haltebecken durch einen elektronischen asynchronen Multivibrator, der im Luftzufuhrsystem (F1, F4) (Mikroprozessorsteuereinheit) enthalten ist, reduziert werden kann, um Gleitkräfte zu beseitigen und den Patienten zu mobilisieren (Pulstherapiemodus).
  12. System nach einem der vorangehenden Ansprüche, bei dem das Trageprofil des Haltebeckens mit einer mechanischen Niveaueinstellung versehen ist, um den sanften Fluidisierungsdruck auf dem Körper eines Patienten so konstant wie möglich zu halten.
EP91909550A 1990-05-28 1991-05-07 Ausrüstung zum inaktivieren der keimschicht bei der fluidisierungstherapie Expired - Lifetime EP0496841B1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
NL9001211A NL9001211A (nl) 1990-05-28 1990-05-28 Uitrusting voor het inactiveren van voedingsbodems bij de fluidisatie therapie.
NL9001211 1990-05-28
PCT/NL1991/000078 WO1991018578A1 (en) 1990-05-28 1991-05-07 Equipment to inactivate matrix at the fluidization therapy

Publications (2)

Publication Number Publication Date
EP0496841A1 EP0496841A1 (de) 1992-08-05
EP0496841B1 true EP0496841B1 (de) 1997-12-29

Family

ID=19857152

Family Applications (1)

Application Number Title Priority Date Filing Date
EP91909550A Expired - Lifetime EP0496841B1 (de) 1990-05-28 1991-05-07 Ausrüstung zum inaktivieren der keimschicht bei der fluidisierungstherapie

Country Status (6)

Country Link
EP (1) EP0496841B1 (de)
AT (1) ATE161415T1 (de)
DE (1) DE69128523T2 (de)
ES (1) ES2110439T3 (de)
NL (1) NL9001211A (de)
WO (1) WO1991018578A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5402542A (en) * 1993-04-22 1995-04-04 Ssi Medical Services, Inc. Fluidized patient support with improved temperature control
US6073289A (en) 1997-12-18 2000-06-13 Hill-Rom, Inc. Air fluidized bed
US6158070A (en) * 1999-08-27 2000-12-12 Hill-Rom, Inc. Coverlet for an air bed
US9763842B2 (en) * 2012-06-27 2017-09-19 Hill-Rom Services, Inc. Fluidizable bed with lateral rotation capability and method of operation therefor

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3428973A (en) * 1966-03-17 1969-02-25 Thomas S Hargest Fluidized supporting apparatus
CH449848A (fr) * 1967-05-09 1968-01-15 J Werding Winfried Lit oscillant automatique
JPS59218151A (ja) * 1983-05-27 1984-12-08 富士電機株式会社 流動式ベツドの昇降制御装置
JPS59218152A (ja) * 1983-05-27 1984-12-08 富士電機株式会社 流動ベツドのかたさ制御装置
JPS61290953A (ja) * 1985-06-19 1986-12-20 富士電機株式会社 身体支持具
US4768250A (en) * 1985-07-30 1988-09-06 Fuji Electric Co., Ltd. Fluidized bead bed
NL8800792A (nl) * 1988-03-29 1989-10-16 Redactron Bv Werkwijze en inrichting voor het onttrekken van vocht aan een of meer lichamen.

Also Published As

Publication number Publication date
DE69128523T2 (de) 1998-04-16
ATE161415T1 (de) 1998-01-15
EP0496841A1 (de) 1992-08-05
DE69128523D1 (de) 1998-02-05
NL9001211A (nl) 1991-12-16
WO1991018578A1 (en) 1991-12-12
ES2110439T3 (es) 1998-02-16

Similar Documents

Publication Publication Date Title
CA1336534C (en) Method and device for abstracting moisture and fluid from one or more bodies
EP3013407B1 (de) Medizinisches behandlungssystem
US8241258B2 (en) Wound treatment system and method of use
CA2044256C (en) A medical apparatus using ozone gas
WO1991018578A1 (en) Equipment to inactivate matrix at the fluidization therapy
CN104323897A (zh) 双恒层流医用悬浮床
CN105167732A (zh) 一种集成水蒸汽喷射灭菌技术与热泵干燥技术的鞋护理机
ES2109649T3 (es) Dispositivo para el tratamiento termico de una banda de tejido conducida continuamente, especialmente una banda textil.
CN202204253U (zh) 低温干燥柜
US5206896A (en) Immobilization of domestic animals in a bed of fluidizable solid particles
CN212139826U (zh) 一种鞋柜
CN114532750A (zh) 一种绿色家具的等离子灭菌衣柜
SE9100174L (sv) Sterilationsfoerfarande och -anordning
CN109395109B (zh) 消毒柜及消毒方法
CN204219214U (zh) 双恒层流医用悬浮床
KR102233717B1 (ko) 신발 소독장치
CN215303966U (zh) 一种消毒烘干鞋柜
CN109481111A (zh) 一种烧伤层流治疗机
CN107777054A (zh) 一种多功能医疗器械盒
GB2022399A (en) Racking systems
JPS6058369B2 (ja) 手術室等の調温調湿装置
JPH01259863A (ja) 美容ルーム
CN113018137A (zh) 一种带红光的砂悬浮治疗床
CN112274415A (zh) 一种中药熏洗设备
US20120110743A1 (en) Fluidizable medium support bed

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE ES FR GB IT LI NL

17P Request for examination filed

Effective date: 19920610

17Q First examination report despatched

Effective date: 19940824

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REDITAC B.V.

GRAG Despatch of communication of intention to grant

Free format text: ORIGINAL CODE: EPIDOS AGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

GRAH Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOS IGRA

RAP3 Party data changed (applicant data changed or rights of an application transferred)

Owner name: REDITAC B.V.

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE CH DE ES FR GB IT LI NL

REF Corresponds to:

Ref document number: 161415

Country of ref document: AT

Date of ref document: 19980115

Kind code of ref document: T

REG Reference to a national code

Ref country code: CH

Ref legal event code: NV

Representative=s name: KELLER & PARTNER PATENTANWAELTE AG

Ref country code: CH

Ref legal event code: EP

REF Corresponds to:

Ref document number: 69128523

Country of ref document: DE

Date of ref document: 19980205

REG Reference to a national code

Ref country code: ES

Ref legal event code: FG2A

Ref document number: 2110439

Country of ref document: ES

Kind code of ref document: T3

ET Fr: translation filed
RIN2 Information on inventor provided after grant (corrected)

Free format text: RYHINER, VICTOR, GEORGE

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed
REG Reference to a national code

Ref country code: GB

Ref legal event code: IF02

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: ES

Payment date: 20020520

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: CH

Payment date: 20020815

Year of fee payment: 12

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: AT

Payment date: 20020819

Year of fee payment: 12

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: AT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030507

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030508

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CH

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030531

Ref country code: LI

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20030531

REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

REG Reference to a national code

Ref country code: ES

Ref legal event code: FD2A

Effective date: 20030508

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20060518

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: BE

Payment date: 20060523

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20060531

Year of fee payment: 16

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: DE

Payment date: 20060707

Year of fee payment: 16

BERE Be: lapsed

Owner name: *REDITAC B.V.

Effective date: 20070531

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20080131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: BE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20071201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070531

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: NL

Payment date: 20080331

Year of fee payment: 18

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20080520

Year of fee payment: 18

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070507

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20090507

NLV4 Nl: lapsed or anulled due to non-payment of the annual fee

Effective date: 20091201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: NL

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20091201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20090507